1219023

Aurobindo Pharma Limited — FEI 3004021263

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 29, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sangareddy (India)

Citations

IDCFRDescription
358521 CFR 211.110(a)Control procedures to monitor and validate performance